Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Paediatr Anaesth ; 16(12): 1226-31, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17121551

ABSTRACT

BACKGROUND: Pediatric patients who undergo diagnostic radiological imaging studies routinely require moderate or deep sedation to a Ramsay Sedation Score (RSS) of 4 or 5, respectively. The correlation between moderate and deep RSS and bispectral index (BIS) in children has never been validated. This study was designed to determine whether the BIS values correlate with RSS of children sedated for diagnostic imaging studies. METHODS: After Institutional Review Board approval, data were prospectively collected on all children receiving pentobarbital alone for computed tomography or magnetic resonance imaging. On arrival in the recovery room, any child assigned a Ramsay score of 4 or 5 was subsequently monitored with the BIS. Receiver-operating characteristic (ROC) analysis was used to evaluate the discriminative ability of BIS in differentiating depth of anesthesia. RESULTS: A total of 86 children over 1 year of age were enrolled. Children with Ramsay 4 (moderate) and Ramsay 5 (deep) sedation scores showed no significant difference in age or pentobarbital dose (mg.kg(-1)). BIS values followed a normal Gaussian-shaped distribution for both Ramsay scores. There was no significant difference in mean BIS values between the Ramsay groups (P = 0.64). There was a wide variation in BIS values (range of 31-90), which demonstrates that the BIS monitor does not correlate with the clinically assigned RSS depth of anesthesia in children. The ROC curve for BIS is equivalent to a line of nondiscrimination. CONCLUSION: BIS has limited ability to distinguish between moderate and deep Ramsay sedation levels in children who receive pentobarbital sedation for diagnostic imaging studies.


Subject(s)
Conscious Sedation/classification , Electroencephalography/drug effects , Hypnotics and Sedatives/administration & dosage , Pentobarbital/administration & dosage , Child , Child, Preschool , Double-Blind Method , Female , Humans , Hypnotics and Sedatives/pharmacology , Magnetic Resonance Imaging , Male , Pentobarbital/pharmacology , Prospective Studies , ROC Curve , Research Design , Tomography, X-Ray Computed
2.
Anesth Analg ; 103(1): 57-62, table of contents, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16790626

ABSTRACT

Dexmedetomidine is a sedative with limited experience in the pediatric population. This is the first study that prospectively evaluates the sedation profile of a dexmedetomidine pilot program for pediatric sedation for radiological imaging studies. In March 2005, our hospital sedation committee approved the replacement of IV pentobarbital with dexmedetomidine as the standard of care for CT imaging. Detailed Quality Assurance (QA) data sheets collect relevant information on each patient, which is then logged into a computerized sedation database. After IRB approval, all QA data was accessed. Sixty-two patients with a mean age of 2.8 years (SD = 1.8, range 0.5-9.7) received IV (IV) dexmedetomidine administered as a 2 mcg/kg loading dose over 10 minutes, followed by repeat boluses of 2 mcg/kg over 10 minutes until target of Ramsay Sedation Score 4 (RSS) achieved. Patients were then maintained on 1 mcg/kg/hr infusion until imaging is completed. Repeated-measures ANOVA indicated that compared to pre-sedation values, the heart rate and mean arterial blood pressure decreased an average of 15% during bolus, infusion and recovery (P < 0.01). No significant changes were observed in respiratory rate or end-tidal CO2. Mean recovery time was 32 +/- 18 minutes. Based on our pilot results, dexmedetomidine may provide a reliable and effective method of providing sedation.


Subject(s)
Conscious Sedation , Dexmedetomidine/administration & dosage , Hypnotics and Sedatives/administration & dosage , Tomography, X-Ray Computed , Child , Child, Preschool , Dexmedetomidine/adverse effects , Female , Humans , Hypnotics and Sedatives/adverse effects , Infant , Infusions, Intravenous , Injections, Intravenous , Male , Oxygen/blood , Pilot Projects
SELECTION OF CITATIONS
SEARCH DETAIL
...